Stocks News

LAST PRICE
247.2100
TODAY'S CHANGE (%)
Trending Down-1.4800 (-0.5951%)

Bid / Lots
236.0000/ 1
Ask / Lots
250.3500/ 4
Open / Previous Close
248.8100 / 248.6900
Day Range
Low 246.1850
High 249.2650
52 Week Range
Low 140.8100
High 260.4900
Volume
735,657
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- Exploring the $188 Billion Opportunity: Why AI is Set to Transform Global Healthcare by 2030, from 8 hours ago by CNW Group
  8 hours ago by CNW Group
  Companies Mentioned: RMD, WHTCF, AVAI, CLOV, HWAIF
  COMTEX_459721183/2669/2024-11-12T09:01:01
Nov 6, 2024
- DJ U.S. Tariffs Could Force Moves by Australian Med-Techs -- Market Talk, from 10:53PM ET on Wednesday Nov 06, 2024 by Dow Jones
  10:53PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: RMD
  
  0353 GMT - Australia-listed drug and device makers may have to consider moving production due to potential tariffs by the incoming Trump administration, UBS analysts write in a note. They say that the likes of vaccine giant CSL, hearing-implant maker Cochlear, breath-tech provider ResMed and radiopharmaceutical developer Telix may have to consider the origin of various inputs and the location of production. Tariffs could motivate relocation of facilities to the U.S. but result in lower profitability for companies, they say. Protective-garment maker Ansell could benefit from tariffs on Chinese gloves, they add. (stuart.condie@wsj.com)
Nov 5, 2024
- ResMed Announces Participation in the UBS Global Healthcare Conference, from 4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
  4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: RMD
  
  ResMed Announces Participation in the UBS Global Healthcare Conference
  
  SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside chat at the UBS Global Healthcare Conference on Tuesday, November 12, 2024, beginning at approximately 3:30 p.m. (Pacific Standard Time) at the Terranea Resort Hotel in Rancho Palos Verdes, CA.
Oct 29, 2024
- SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of ResMed Inc. (NYSE:RMD) and Encourages Investors to Contact the Firm, from 8:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
  8:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
  Companies Mentioned: RMD
  
  SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of ResMed Inc. (NYSE:RMD) and Encourages Investors to Contact the Firm
  
  PHILADELPHIA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating ResMed Inc. (NYSE:RMD) on behalf of the company's shareholders.
Oct 27, 2024
- DJ ResMed's External Drivers Look Strong to Bull -- Market Talk, from 8:19PM ET on Sunday Oct 27, 2024 by Dow Jones
  8:19PM ET on Sunday Oct 27, 2024 by Dow Jones
  Companies Mentioned: RMD
  
  0019 GMT - ResMed's bulls at Wilsons say external demand drivers are the most powerful they've seen in 16 years covering the breathing-tech provider. The broker's analysts point to the positive impact of rising health awareness from smart devices, plus obesity treatment and awareness. ResMed's market dominance and tech capabilities also support their continued overweight recommendation. With the stock rallying to trade at 20X Ebitda, they call recent worries over the potential impact of weight-loss drugs "nonsense". Wilsons lifts the stock's target price 4.8% to A$42.18. Shares are up 1.5% at A$38.29.(stuart.condie@wsj.com)

Today
- Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW, from 6 minutes ago by Dow Jones
  6 minutes ago by Dow Jones
  Companies Mentioned: EW
- EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit, from 20 minutes ago by PR Newswire
  20 minutes ago by PR Newswire
  Companies Mentioned: EW
- EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit, from 20 minutes ago by Dow Jones
  20 minutes ago by Dow Jones
  Companies Mentioned: EW
- EW LEGAL ALERT: Edwards Lifesciences (EW) was Sued for Fraud - Investors are Urged to Contact BFA Law by December 13 Court Deadline, from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: EW
- Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before December 13, 2024 to Discuss Your Rights -- EW, from 4 hours ago by Dow Jones
  4 hours ago by Dow Jones
  Companies Mentioned: EW
- Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: EW
- Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation, from 6 hours ago by Dow Jones
  6 hours ago by Dow Jones
  Companies Mentioned: EW
- Veeva Systems Insider Sold Shares Worth $270,252, According to a Recent SEC Filing, from 6 hours ago by MT Newswires
  6 hours ago by MT Newswires
  Companies Mentioned: VEEV
- EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline, from 6 hours ago by Dow Jones
  6 hours ago by Dow Jones
  Companies Mentioned: EW
- After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman, from 7 hours ago by Newsfile
  7 hours ago by Newsfile
  Companies Mentioned: EW

Resmed Inc
NYSE:RMDUnited States

Search Criteria

Today

Exploring the $188 Billion Opportunity: Why AI is Set to Transform Global Healthcare by 2030, from 8 hours ago by CNW Group

Nov 6, 2024

DJ U.S. Tariffs Could Force Moves by Australian Med-Techs -- Market Talk, from 10:53PM ET on Wednesday Nov 06, 2024 by Dow Jones

Nov 5, 2024

ResMed Announces Participation in the UBS Global Healthcare Conference, from 4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones

Oct 29, 2024

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of ResMed Inc. (NYSE:RMD) and Encourages Investors to Contact the Firm, from 8:30AM ET on Tuesday Oct 29, 2024 by Dow Jones

Oct 27, 2024

DJ ResMed's External Drivers Look Strong to Bull -- Market Talk, from 8:19PM ET on Sunday Oct 27, 2024 by Dow Jones

Peers Headlines

Today

Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW, from 6 minutes ago by Dow Jones

EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit, from 20 minutes ago by PR Newswire

EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit, from 20 minutes ago by Dow Jones

EW LEGAL ALERT: Edwards Lifesciences (EW) was Sued for Fraud - Investors are Urged to Contact BFA Law by December 13 Court Deadline, from 1 hour ago by Dow Jones

Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before December 13, 2024 to Discuss Your Rights -- EW, from 4 hours ago by Dow Jones

Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW, from 5 hours ago by Dow Jones

Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation, from 6 hours ago by Dow Jones

Veeva Systems Insider Sold Shares Worth $270,252, According to a Recent SEC Filing, from 6 hours ago by MT Newswires

EW LAWSUIT ALERT: Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline, from 6 hours ago by Dow Jones

After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman, from 7 hours ago by Newsfile